Sensitive thyrotropin assays: analytic and clinical performance criteria

G. G. Klee, Ian D Hay

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Thyrotropin (TSH) measurements in serum traditionally have been used for the diagnosis and management of hypothyroidism; the availability of highly sensitive TSH assays has expanded the utility of these measurements to include detection of hyperthyroidism, monitoring of thyroxine replacement therapy, and front-line assessment of thyroid function. The analytic advancement that has expanded TSH utility is the noncompetitive 'sandwich' immunoassay, which is faster and more sensitive than traditional radioimmunoassays. All such assays, however, are not equivalent; therefore, we have developed analytic and clinical performance criteria for evaluating sensitive TSH assays. These criteria are as follows: (1) the overlap between the assay detection limit and the lower limit of normal should be less than 1%, (2) basal TSH measurements should predict the TSH response to thyrotropin releasing hormone stimulation at least 95% of the time, and (3) basal TSH measurements should be 95% sensitive and 95% specific for detecting hyperthyroidism. Three allegedly sensitive TSH assays were evaluated: (1) the Hybritech two-step Tandem-R method (assay A), (2) the semiautomated Boots-Celltech Sucrosep method (assay B), and (3) a modified Ciba Corning Magic Lite method (assay C). Both assay B and assay C fulfilled our criteria for a sensitive assay; assay B had slightly better performance, and assay C was easier to perform.

Original languageEnglish (US)
Pages (from-to)1123-1132
Number of pages10
JournalMayo Clinic Proceedings
Volume63
Issue number11
StatePublished - 1988

Fingerprint

Thyrotropin
Hyperthyroidism
Magic
Thyrotropin-Releasing Hormone
Hypothyroidism
Thyroxine
Immunoassay
Radioimmunoassay
Limit of Detection
Thyroid Gland
Serum
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sensitive thyrotropin assays : analytic and clinical performance criteria. / Klee, G. G.; Hay, Ian D.

In: Mayo Clinic Proceedings, Vol. 63, No. 11, 1988, p. 1123-1132.

Research output: Contribution to journalArticle

@article{d35720abc72e480ead3475b7493a56ed,
title = "Sensitive thyrotropin assays: analytic and clinical performance criteria",
abstract = "Thyrotropin (TSH) measurements in serum traditionally have been used for the diagnosis and management of hypothyroidism; the availability of highly sensitive TSH assays has expanded the utility of these measurements to include detection of hyperthyroidism, monitoring of thyroxine replacement therapy, and front-line assessment of thyroid function. The analytic advancement that has expanded TSH utility is the noncompetitive 'sandwich' immunoassay, which is faster and more sensitive than traditional radioimmunoassays. All such assays, however, are not equivalent; therefore, we have developed analytic and clinical performance criteria for evaluating sensitive TSH assays. These criteria are as follows: (1) the overlap between the assay detection limit and the lower limit of normal should be less than 1{\%}, (2) basal TSH measurements should predict the TSH response to thyrotropin releasing hormone stimulation at least 95{\%} of the time, and (3) basal TSH measurements should be 95{\%} sensitive and 95{\%} specific for detecting hyperthyroidism. Three allegedly sensitive TSH assays were evaluated: (1) the Hybritech two-step Tandem-R method (assay A), (2) the semiautomated Boots-Celltech Sucrosep method (assay B), and (3) a modified Ciba Corning Magic Lite method (assay C). Both assay B and assay C fulfilled our criteria for a sensitive assay; assay B had slightly better performance, and assay C was easier to perform.",
author = "Klee, {G. G.} and Hay, {Ian D}",
year = "1988",
language = "English (US)",
volume = "63",
pages = "1123--1132",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "11",

}

TY - JOUR

T1 - Sensitive thyrotropin assays

T2 - analytic and clinical performance criteria

AU - Klee, G. G.

AU - Hay, Ian D

PY - 1988

Y1 - 1988

N2 - Thyrotropin (TSH) measurements in serum traditionally have been used for the diagnosis and management of hypothyroidism; the availability of highly sensitive TSH assays has expanded the utility of these measurements to include detection of hyperthyroidism, monitoring of thyroxine replacement therapy, and front-line assessment of thyroid function. The analytic advancement that has expanded TSH utility is the noncompetitive 'sandwich' immunoassay, which is faster and more sensitive than traditional radioimmunoassays. All such assays, however, are not equivalent; therefore, we have developed analytic and clinical performance criteria for evaluating sensitive TSH assays. These criteria are as follows: (1) the overlap between the assay detection limit and the lower limit of normal should be less than 1%, (2) basal TSH measurements should predict the TSH response to thyrotropin releasing hormone stimulation at least 95% of the time, and (3) basal TSH measurements should be 95% sensitive and 95% specific for detecting hyperthyroidism. Three allegedly sensitive TSH assays were evaluated: (1) the Hybritech two-step Tandem-R method (assay A), (2) the semiautomated Boots-Celltech Sucrosep method (assay B), and (3) a modified Ciba Corning Magic Lite method (assay C). Both assay B and assay C fulfilled our criteria for a sensitive assay; assay B had slightly better performance, and assay C was easier to perform.

AB - Thyrotropin (TSH) measurements in serum traditionally have been used for the diagnosis and management of hypothyroidism; the availability of highly sensitive TSH assays has expanded the utility of these measurements to include detection of hyperthyroidism, monitoring of thyroxine replacement therapy, and front-line assessment of thyroid function. The analytic advancement that has expanded TSH utility is the noncompetitive 'sandwich' immunoassay, which is faster and more sensitive than traditional radioimmunoassays. All such assays, however, are not equivalent; therefore, we have developed analytic and clinical performance criteria for evaluating sensitive TSH assays. These criteria are as follows: (1) the overlap between the assay detection limit and the lower limit of normal should be less than 1%, (2) basal TSH measurements should predict the TSH response to thyrotropin releasing hormone stimulation at least 95% of the time, and (3) basal TSH measurements should be 95% sensitive and 95% specific for detecting hyperthyroidism. Three allegedly sensitive TSH assays were evaluated: (1) the Hybritech two-step Tandem-R method (assay A), (2) the semiautomated Boots-Celltech Sucrosep method (assay B), and (3) a modified Ciba Corning Magic Lite method (assay C). Both assay B and assay C fulfilled our criteria for a sensitive assay; assay B had slightly better performance, and assay C was easier to perform.

UR - http://www.scopus.com/inward/record.url?scp=0023709305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023709305&partnerID=8YFLogxK

M3 - Article

C2 - 3057295

AN - SCOPUS:0023709305

VL - 63

SP - 1123

EP - 1132

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 11

ER -